On February 13, 2020, the U.S. Food and Drug Administration (FDA) requested that the manufacturer of the weight-loss drugs Belviq and Belviq XR (lorcaserin) remove their drugs from the market. The FDA cautioned that patients taking these drugs were at an increased risk of developing cancer.
If you or a loved one took Belviq or Belviq XR and developed cancer, you may be entitled to substantial compensation.
https://www.kishishlaw.com/belviq-lawsuit